About Recursion Pharmaceuticals
Recursion Pharmaceuticals is a leading organisation in the biotech & genomics sector. Like most biotech & genomics organisations at scale, they faced growing operational complexity — more volume, higher expectations, and a workforce stretched thin by routine but critical tasks.
The Problem
Recursion's scientists generated terabytes of biological imaging data weekly but needed AI that could synthesise scientific literature, interpret experimental results, and connect findings to published research at a pace matching their discovery programmes.
How They Used Claude
Integrated Claude into their scientific intelligence platform, enabling researchers to query the entirety of published biomedical literature in natural language, cross-reference experimental findings, and generate hypothesis documents for team review.
Measurable Outcomes
- ✓ Literature review time per programme reduced by 70%
- ✓ Hypothesis generation cycle time cut from 6 weeks to 10 days
- ✓ Scientific report drafting time reduced by 60%
- ✓ Researcher satisfaction with knowledge management up 54%
"Claude allows our scientists to think at the speed of biology, not the speed of literature searching."
— Recursion Pharmaceuticals · Source: Recursion Pharmaceuticals technology announcements + Nature Biotechnology features (2024)
Key Lessons for Biotech & Genomics Organisations
Start with a clearly scoped pilot — one use case, one team, 30 days.
Measure baseline metrics before deployment so ROI is unambiguous.
Executive sponsorship drives adoption; middle management drives usage.
Invest in training alongside technology — adoption is 80% people, 20% product.